Last $26.94 USD
Change Today +0.08 / 0.30%
Volume 222.4K
CSII On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 4:00 PM 09/22/14 All times are local (Market data is delayed by at least 15 minutes).

cardiovascular systems inc (CSII) Snapshot

Open
$26.67
Previous Close
$26.86
Day High
$27.01
Day Low
$26.51
52 Week High
02/24/14 - $37.73
52 Week Low
10/3/13 - $18.83
Market Cap
849.3M
Average Volume 10 Days
173.5K
EPS TTM
$-1.24
Shares Outstanding
31.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CARDIOVASCULAR SYSTEMS INC (CSII)

cardiovascular systems inc (CSII) Related Bloomberg News

View More Bloomberg News

cardiovascular systems inc (CSII) Related Businessweek News

No Related Businessweek News Found

cardiovascular systems inc (CSII) Details

Cardiovascular Systems, Inc., a medical device company, develops, manufactures, and markets devices for the treatment of vascular diseases. Its products include catheter-based platforms, such as the Stealth 360° Peripheral Orbital Atherectomy System (OAS), Diamondback 360 Peripheral OAS, Stealth 360° peripheral artery disease (PAD) System, Diamondback 360° PAD System, and Diamondback Predator 360° PAD System that are used for the treatment of a range of plaque types in leg arteries above and below the knee. The company markets its products through direct sales force to hospitals and office-based labs. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in St. Paul, Minnesota.

479 Employees
Last Reported Date: 08/28/14
Founded in 1989

cardiovascular systems inc (CSII) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $500.0K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $321.1K
Chief Healthcare Policy Officer
Total Annual Compensation: $303.2K
Chief Administrative Officer, Compliance Offi...
Total Annual Compensation: $286.7K
Executive Vice President of Sales & Marketing
Total Annual Compensation: $288.8K
Compensation as of Fiscal Year 2013.

cardiovascular systems inc (CSII) Key Developments

Cardiovascular Systems, Inc. Announces Executive Changes

Cardiovascular Systems Inc. announced that its chairman of the board, Glen D. Nelson, M.D. plans to retire and will not stand for re-election at the company's 2014 annual meeting of shareholders on November 12, 2014--when his term ends. In appreciation for his eleven years of service as a CSI board member--seven as chairman--the board named Dr. Nelson chairman emeritus, an honorary title. Scott R. Ward, a CSI director since 2013, will be named chairman. Ward is a managing director at SightLine Partners, LLC. He has over thirty years of experience in Medical Technology.

Cardiovascular Systems Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended June 30, 2014; Provides Earnings Guidance for the Fiscal 2015

Cardiovascular Systems Inc. announced unaudited consolidated earnings results for the fourth quarter and year ended June 30, 2014. For the quarter, the company reported revenues of $39,564,000 compared to $28,821,000 a year ago. Loss from operations was $9,554,000 compared to $6,681,000 a year ago. Net loss and comprehensive loss was $9,628,000 or $0.31 per basic and diluted share compared to $6,841,000 or $0.28 per basic and diluted share a year ago. Adjusted LBITDA was $5,921,000 compared to $4,270,000 a year ago. Losses increased from the prior year primarily due to planned investments, including $11.7 million of expenses related to coronary market launch initiatives, clinical studies and new product development. Excluding net coronary investments, adjusted EBITDA was positive for the quarter. For the year, the company reported revenues of $136,612,000 compared to $103,897,000 a year ago. Loss from operations was $33,489,000 compared to $22,419,000 a year ago. Net loss and comprehensive loss was $35,290,000 or $1.25 per basic and diluted share compared to $24,037,000 or $1.11 per basic and diluted share a year ago. Adjusted LBITDA was $21,192,000 compared to $14,004,000 a year ago. Excluding net coronary investments, adjusted EBITDA was positive for the full year. For the fiscal 2015 first quarter ending September 30, 2014, the company anticipates: revenue growth of 33% to 37% over the first quarter of fiscal 2014, to a range of $39.5 million to $40.7 million; Gross profit as a percentage of revenues of 77.5% to 78.0%; Operating expenses approximately 4% to 5% higher than the fourth quarter of fiscal 2014, primarily to advance the coronary commercial launch, clinical studies, and product development, as well as the timing of sales meetings and conferences; and Net loss in the range of $10.3 million to $11.0 million, or loss per common share ranging from $0.33 to $0.35, assuming 31.3 million average shares outstanding.

Cardiovascular Systems Inc. to Report Q4, 2014 Results on Aug 06, 2014

Cardiovascular Systems Inc. announced that they will report Q4, 2014 results After-Market on Aug 06, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CSII:US $26.94 USD +0.08

CSII Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AtriCure Inc $14.87 USD -0.11
CryoLife Inc $10.17 USD -0.04
Endologix Inc $13.79 USD -0.25
Spectranetics Corp/The $27.53 USD -0.51
Vascular Solutions Inc $23.16 USD -0.30
View Industry Companies
 

Industry Analysis

CSII

Industry Average

Valuation CSII Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.1x
Price/Book 5.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 5.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CARDIOVASCULAR SYSTEMS INC, please visit www.csi360.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.